USpharma Ltd
FDA inspection history in Miami Lake, Florida, 2022 to 2023
- 2
- Form 483s
Every document, by year
- Form 483
2022: one Form 483; 2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022–23Two Form 483s, at Miami Lake, Florida.
- 2022The longest 483 on file: 3 observations over 4 pages at Miami Lake, Florida.
Cited most
Across all USpharma observations on file
- 21 CFR 211.165(e)Testing and release for distribution1
- 21 CFR 211.192Production record review1
- 21 CFR 211.194(a)(4)Laboratory records1
- 21 CFR 803.50(a)(1)If I am a manufacturer, what reporting requirements apply to me?1
The complete USpharma file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Miami Lake, Florida
Two Form 483s · 2022 to 2023 · 4 observations
Latest: Form 483, May 11, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-05-11 | 483 Form 483 | Miami Lake, Florida | 1 | $99 |
| 2022-06-23 | 483 Form 483 | Miami Lake, Florida | 3 | $99 |
Investigators on these documents
FEI number 1010370 · most recent document May 11, 2023
About USpharma Ltd
How many FDA Form 483s has USpharma Ltd received?
FDA Intel has 2 Form 483s on file for USpharma Ltd; the most recent is dated May 11, 2023.
When was USpharma Ltd last inspected by FDA?
The most recent FDA inspection document on file for USpharma Ltd is a Form 483 dated May 11, 2023, for the site in Miami Lake, Florida.
What did FDA cite at USpharma Ltd?
The regulations cited most in the observations on file for USpharma Ltd are 21 CFR 211.165(e) (Testing and release for distribution), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.194(a)(4) (Laboratory records), 1 time.